Portal de investigación
Randomized phase IIb clinical trial of continuation or non-continuation with six cycles of temozolomide after the first six cycles of standard first-line treatment in patients with glioblastoma: A Spanish research group in neuro-oncology (GEINO) trial.
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Balana, C
- Barroso, CM
- Berron, SD
- Losada, EP
- Estival, A
- De las Penas, R
- Fuster, J
- Gil, MJG
- Navarro, LM
- Alonso, M
- Herrero, A
- Salgado, MAV
- Peralta, S
- Olier, C
- Perez-Segura, P
- Rua, MC
- Carrato, C
- Sanz, C
- Sepulveda-Sanchez, JM
Grupos
Abstract
Abstract no disponible
Datos de la publicación
- ISSN/ISSNe:
- 0732-183X, 1527-7755
- Tipo:
- Meeting Abstract
- Páginas:
- -
- Factor de Impacto:
- 10,054 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
JOURNAL OF CLINICAL ONCOLOGY LIPPINCOTT WILLIAMS & WILKINS
Citas Recibidas en Web of Science: 2
Documentos
- No hay documentos
Filiaciones
Filiaciones no disponibles
Campos de Estudio
Cita
Balana,C,Barroso,CM,Berron,SD,Losada,EP,Munoz,J,Estival,A,De las Penas,R et al. Randomized phase IIb clinical trial of continuation or non-continuation with six cycles of temozolomide after the first six cycles of standard first-line treatment in patients with glioblastoma: A Spanish research group in neuro-oncology (GEINO) trial. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO). 2019. Chicago-IL. TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103:LIPPINCOTT WILLIAMS & WILKINS. 2019.